Fosmidomycin (FR-31564), a phosphonic acid derivative, was combined with cefazolin, cephalexin, ampicillin, carbenicillin, ticarcillin, gentamicin, and trimethoprim. Synergy between fosmidomycin and penicillins or cephalosporins was found for 37 to 52% of the Enterobacteriaceae tested. Synergy with trimethoprim was found against 55% of bacteria isolated, but only 17% of the strains showed synergy between formidomycin and gentamicin. Synergy between fosmidomycin and ticarcillin was shown for 35% of the Pseudomonas isolates. Cefazolin-, ampicillin-, and gentamicin-resistant isolates of various species were synergistically inhibited by fosmidomycin, as were ticarcillin-and gentamicinresistant isolates. Antagonism was not encountered. This study illustrates another example of synergistic activity of compounds which attack different mechanisms in bacterial cells.
1
Phosphonic acid compounds such as fosfomycin and fosmidomycin (FR-31564) interfere with cell wall synthesis in gram-positive and gramnegative bacteria. These agents inhibit the inital step in cell wall synthesis by inhibiting phosphoenolpyruvate synthetase. These agents may interact synergistically with other inhibitors of cell wall synthesis that act at later steps by producing blockades at more than one point in the synthetic pathway. Furthermore, fosmidomycin might act synergistically with antibiotics whose site of action is within the cell by allowing the increased entry of compounds, such as aminoglycosides, which have been shown to act synergistically with compounds which interfere with cell wall synthesis. MATERIALS Overall, the combination of fosmidomycin with other agents showed synergy with ampicillin (52%), ticarcillin (47%), carbenicillin (37%), cephalexin (61%), cefazolin (50%), trimethoprim (55%), and gentamicin (17%).
Examples of the antimicrobial activity of fosmidomycin and other antibiotics combined at a 1:1 ratio against bacterial isolates resistant to other antibiotics are shown in Table 2 . All 13 isolates resistant to cefazolin were synergistically inhibited by the combination offosmidomycin and cefazolin. The combination showed synergy against 16 of 17 ampicillin-resistant isolates. Synergy between cephalexin and fosmidomycin was found for 11 of 13 cephalexin-resistant isolates. Synergy between gentamicin and fosmidomycin was found for 7 of 11 gentamicin-resistant strains. The combination of fosmidomycin with another antibiotic frequently was synergistic when the organisms were resistant to fosmidomycin (Table 3) .
Variation in the concentration of the P-lactam from a 1:1 ratio to a fosmidomycin/,B-lactam ratio of 1:4 was investigated. For example, an Enterobacter aerogenes strain with a fosmidomycin MIC of 6.25 ,ug/ml and a cefazolin MIC of 25 ,ug/ml at a 1:1 ratio had a combination MIC of 1.56 ,jg/ml and an FIC index of 0.26; at 1:4 ratio, the strain had a combination MIC of 1.56 ,ug/ml, yielding FIC index of 0.12. Of the 24 isolates of Escherichia coli, K. pneumoniae, C. freundii, Enterobacter cloacae, Enterobacter aerogenes, and Serratia marcescens tested at fosmidomycin/cefazolin ratios of 1:1 and 1:4, synergy was found at the 1:1 ratio for 54% and at the 1:4 ratio for 79o of the isolates.
There has been a discrepancy between MIC and MBC values with fosmidomycin. For this reason, we evaluated the effect of the combination of fosmidomycin and ,-lactams on MBC values. Table 4 shows such examples which show that synergy is achieved in terms of both the MIC and the MBC.
To determine whether the synergistic effect of the combination of fosmidomycin and cefazolin or fosmidomycin and ampicillin was present in urine as well as in broth we pooled human urine and determined the effect of the combination of fosmidomycin with the 1-lactams in both nutrient broth and urine. Urine was used since highsolute concentrations decrease the activity of fosmidomycin. At 3 h, there was a 2-log reduction in the number of colonies at concentrations of drugs that were 4-to 16-fold below the MIC for both fosmidomycin-ampicillin and fosmidomycin-cefazolin.
DISCUSSION
The synergistic combination of antimicrobial agents has been investigated for many drugs. The most widely used combination of antimicrobial agents has been of P-lactams and aminoglycosides. However, the combination of mecillinam with other penicillins showed that the combination of two P-lactams could result in synergy (4). Fosmidomycin is a phosphonic acid agent which inhibits a large number of aerobic gram-negative bacteria (3, 5) . The compound appears to interfere with bacterial cell wall synthesis by inhibiting phosphoenolpyruvate synthetase in a manner analogous to that of fosfomycin (2) . It has been demonstrated by a number of investigators (1, 6, 7) that fosfomycin interacts synergistically with both P-lactams and other antimicrobial agents against a number of different bacteria. This study demonstrates that fosmidomycin also acts synergistically with Plactams, trimethoprim, and to a lesser degree, gentamicin. Generally, strains resistant to ,-lactams were synergistically inhibited at a combination of fosmidomycin and another drug. Other investigators (8) have found generally similar results, but they did report antagonism. The difference between this study and that of Yokota et al. (8) appears to be due to different definitions of antagonism.
